Sequence-dependent denaturation energetics:: A major determinant in amyloid disease diversity

被引:308
作者
Hammarström, P
Jiang, X
Hurshman, AR
Powers, ET
Kelly, JW
机构
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.202495199
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Several misfolding diseases commence when a secreted folded protein encounters a partially denaturing microenvironment, enabling its self assembly into amyloid. Although amyloidosis is modulated by numerous environmental and genetic factors, single point mutations within the amyloidogenic protein can dramatically influence disease phenotype. Mutations that destabilize the native state predispose an individual to disease; however, thermodynamic stability alone does not reliably predict disease severity. Here we show that the rate of transthyretin (TrR) tetramer dissociation required for amyloid formation is strongly influenced by mutation (V30M, L55P, T119M, V122I), with rapid rates exacerbating and slow rates reducing amyloidogenicity. Although these rates are difficult to predict a priori, they notably influence disease penetrance and age of onset. L55P TTR exhibits severe pathology because the tetramer both dissociates quickly and is highly destabilized. Even though V30M and L55P TTR are similarly destabilized, the V30M disease phenotype is milder because V30M dissociates more slowly, even slower than wild type (WT). Although WT and V122I TTR have nearly equivalent tetramer stabilities, V122I cardiomyopathy, unlike WT cardiomyopathy, has nearly complete penetrance-presumably because of its 2-fold increase in dissociation rate. We show that the T119M homotetramer exhibits kinetic stabilization and therefore dissociates exceedingly slowly, likely explaining how it functions to protect V30M/T119M compound heterozygotes from disease. An understanding of how mutations influence both the kinetics and thermodynamics of misfolding allows us to rationalize the phenotypic diversity of amyloid diseases, especially when considered in concert with other genetic and environmental data.
引用
收藏
页码:16427 / 16432
页数:6
相关论文
共 34 条
[1]   A PROTEIN-FOLDING REACTION UNDER KINETIC CONTROL [J].
BAKER, D ;
SOHL, JL ;
AGARD, DA .
NATURE, 1992, 356 (6366) :263-265
[2]   Folding of prion protein to its native α-helical conformation is under kinetic control [J].
Baskakov, IV ;
Legname, G ;
Prusiner, SB ;
Cohen, FE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :19687-19690
[3]   Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis [J].
Booth, DR ;
Sunde, M ;
Bellotti, V ;
Robinson, CV ;
Hutchinson, WL ;
Fraser, PE ;
Hawkins, PN ;
Dobson, CM ;
Radford, SE ;
Blake, CCF ;
Pepys, MB .
NATURE, 1997, 385 (6619) :787-793
[4]   Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants [J].
Canet, D ;
Sunde, M ;
Last, AM ;
Miranker, A ;
Spencer, A ;
Robinson, CV ;
Dobson, CM .
BIOCHEMISTRY, 1999, 38 (20) :6419-6427
[5]   Detection of two partially structured species in the folding process of the amyloidogenic protein β2-microglobulin [J].
Chiti, F ;
Mangione, P ;
Andreola, A ;
Giorgetti, S ;
Stefani, M ;
Dobson, CM ;
Bellottl, V ;
Taddei, N .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (01) :379-391
[6]   Familial amyloid polyneuropathy: New developments in genetics and treatment [J].
Coelho, T .
CURRENT OPINION IN NEUROLOGY, 1996, 9 (05) :355-359
[7]   PARTIAL DENATURATION OF TRANSTHYRETIN IS SUFFICIENT FOR AMYLOID FIBRIL FORMATION INVITRO [J].
COLON, W ;
KELLY, JW .
BIOCHEMISTRY, 1992, 31 (36) :8654-8660
[8]   Protein misfolding, evolution and disease [J].
Dobson, CM .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (09) :329-332
[9]   Protein aggregation: folding aggregates, inclusion bodies and amyloid [J].
Fink, AL .
FOLDING & DESIGN, 1998, 3 (01) :R9-R23
[10]   Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? [J].
Goldberg, MS ;
Lansbury, PT .
NATURE CELL BIOLOGY, 2000, 2 (07) :E115-E119